Log in
Enquire now
‌

US Patent 9567399 Antibodies and immunocytokines

Patent 9567399 was granted and assigned to Kymab on February, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Kymab
Kymab
0
Date Filed
July 15, 2016
0
Date of Patent
February 14, 2017
0
Patent Applicant
Kymab
Kymab
0
Patent Application Number
15211504
0
Patent Citations Received
‌
US Patent 11850262 Compositions and methods for CAR T cell therapy
0
‌
US Patent 11858996 Anti-ICOS antibodies
0
‌
US Patent 11884720 Antibody constructs for MSLN and CD3
0
‌
US Patent 12134648 Dual specificity antibodies to human PD-L1 and PD-L2 and methods of use therefor
0
‌
US Patent 11759480 Compositions and methods for CAR T cell therapy
‌
US Patent 11976128 Human PD-L2 antibodies and methods of use therefor
0
‌
US Patent 11753479 Nucleic acids encoding anti-OX40L antibodies
‌
US Patent 12103976 Fc binding fragments comprising a CD137 antigen-binding site
0
‌
US Patent 11773176 Multispecific antibodies, compositions comprising the same, and vectors and uses thereof
‌
US Patent 11773175 Antibodies, uses and methods
•••
Patent Inventor Names
Nikole Sandy
0
Cassandra van Krinks
0
Ian Kirby
0
Jamie Campbell
0
Miha Kosmac
0
Stephen D. Gillies
0
Steve Arkinstall
0
Thomas Gallagher
0
Volker Germaschewski
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9567399
0
Patent Primary Examiner
‌
Ilia Ouspenski
0

Find more entities like US Patent 9567399 Antibodies and immunocytokines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.